Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
3
×
life sciences
national blog main
national top stories
rna interference
3
×
alexion pharmaceuticals
alnylam pharmaceuticals
boehringer ingelheim
boston
fda
hepatitis b
alirocumab
alnylam pharmaceutials
amgen
arrowhead pharmaceuticals
dicerna pharamceuticals
dicerna pharmaceuticals
eli lilly
evolocumab
hepatitis b virus
hereditary transthyretin amyloidosis
inclisiran
indiana blog main
indiana top stories
johnson & johnson
neurodegenerative diseases
new york
new york blog main
new york top stories
novartis
patisiran
pcsk9
pcsk9 inhibitors
primary hyperoxaluria
regeneron pharmaceuticals
roche
What
medicines
3
×
deal
dicerna
drug
pharma
abandoning
acquire
ago
agreed
baggage
billion
brings
cash
caught
causing
cholesterol
companies
company
compound
cuts
development
disease
eye
fda
free
gene
gets
hepatitis
intended
interference
long
medco
new
novartis
pay
pharmaceuticals
poised
producing
protein
ready
Language
unset
Current search:
deals
×
medicines
×
" rna interference "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M